|Articles|January 29, 2020
Thorough and Reproducible Analytical Characterization of an Innovator and Biosimilar Pair
Author(s)Agilent Technologies
• Solutions for comparing innovator and biosimilar mAbs • Biosimilar case studies
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
4
How Engineered Exosomes Can Impact Targeted Therapies
5
